112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Penas-Prado M, Armstrong TS, Gilbert MR. Progress in rare central nervous system tumors. Current Opinion in Neurology. PMID 31577601 DOI: 10.1097/WCO.0000000000000755  1
2019 Acquaye AA, Payén SS, Vera E, Williams LA, Gilbert MR, Weathers SP, Armstrong TS. Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews. Journal of Patient-Reported Outcomes. 3: 58. PMID 31444579 DOI: 10.1186/s41687-019-0143-0  1
2019 Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert J, LaRocca R, O'Rourke DM, Fink K, Kim L, et al. A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31320597 DOI: 10.1158/1078-0432.CCR-19-0261  0.44
2019 Truitt G, Gittleman H, Leece R, Ostrom QT, Kruchko C, Armstrong TS, Gilbert MR, Barnholtz-Sloan JS. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT. Journal of Neuro-Oncology. PMID 31209773 DOI: 10.1007/s11060-019-03215-x  1
2019 Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, et al. Barriers to Accrual and Enrollment in Brain Tumor Trials. Neuro-Oncology. PMID 31175826 DOI: 10.1093/neuonc/noz104  0.6
2019 Waddle MR, Oudenhoven MD, Farin CV, Deal AM, Hoffman R, Yang H, Peterson J, Armstrong TS, Ewend MG, Wu J. Impacts of Surgery on Symptom Burden and Quality of Life in Pituitary Tumor Patients in the Subacute Post-operative Period. Frontiers in Oncology. 9: 299. PMID 31065545 DOI: 10.3389/fonc.2019.00299  0.44
2018 Leeper HE, Acquaye AA, Bell S, Clarke JL, Forst D, Laack NN, Link MJ, Taylor JW, Armstrong TS. Survivorship care planning in neuro-oncology. Neuro-Oncology Practice. 5: 3-9. PMID 31386011 DOI: 10.1093/nop/npx034  0.8
2018 Armstrong TS, Vera E, Zhou R, Acquaye AA, Sullaway CM, Berger AM, Breton G, Mahajan A, Wefel JS, Gilbert MR, Bondy M, Scheurer ME. Association of genetic variants with fatigue in patients with malignant glioma. Neuro-Oncology Practice. 5: 122-128. PMID 31386001 DOI: 10.1093/nop/npx020  1
2018 Vera E, Acquaye AA, Mendoza TR, Gilbert MR, Armstrong TS. Relationship between symptom burden and health status: analysis of the MDASI-BT and EQ-5D. Neuro-Oncology Practice. 5: 56-63. PMID 31385972 DOI: 10.1093/nop/npx010  1
2018 Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, ... ... Armstrong TS, et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica. PMID 30019219 DOI: 10.1007/s00401-018-1888-x  1
2018 Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, et al. Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology. PMID 29788429 DOI: 10.1093/neuonc/noy056  0.44
2018 Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ, Movsas B. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. Neurosurgery. PMID 29618054 DOI: 10.1093/neuros/nyy003  1
2018 Dirven L, Armstrong TS, Blakeley JO, Brown PD, Grant R, Jalali R, Leeper H, Mendoza T, Nayak L, Reijneveld JC, Rhun EL, Walbert T, Weller M, Wen PY, Taphoorn MJB. Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative. The Lancet. Oncology. 19: e173-e180. PMID 29508764 DOI: 10.1016/S1470-2045(18)30004-4  0.72
2017 Aggarwal SS, Ott SD, Padhye NS, Meininger JC, Armstrong TS. Clinical and demographic predictors of concussion resolution in adolescents: A retrospective study. Applied Neuropsychology. Child. 1-11. PMID 29058480 DOI: 10.1080/21622965.2017.1381099  0.52
2016 Acquaye AA, Vera E, Gilbert MR, Armstrong TS. Clinical presentation and outcomes for adult ependymoma patients. Cancer. PMID 27679985 DOI: 10.1002/cncr.30355  1
2016 Avila EK, Chamberlain M, Schiff D, Reijneveld JC, Armstrong TS, Ruda R, Wen PY, Weller M, Koekkoek JA, Mittal S, Arakawa Y, Choucair A, Gonzalez-Martinez J, MacDonald DR, Nishikawa R, et al. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro-Oncology. PMID 27651472 DOI: 10.1093/neuonc/now190  0.44
2016 Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM. Sleep-wake disturbance in patients with brain tumors. Neuro-Oncology. PMID 27286798 DOI: 10.1093/neuonc/now119  1
2016 Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, ... ... Armstrong TS, et al. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269943 DOI: 10.1200/JCO.2015.65.7825  1
2016 Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro-Oncology. PMID 27022130 DOI: 10.1093/neuonc/now016  1
2016 Helfer JL, Wen PY, Blakeley J, Gilbert MR, Armstrong TS. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD). Neuro-Oncology. 18: ii26-ii36. PMID 26989130 DOI: 10.1093/neuonc/nov270  1
2016 Armstrong TS, Bishof AM, Brown PD, Klein M, Taphoorn MJ, Theodore-Oklota C. Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report. Neuro-Oncology. 18: ii1-ii12. PMID 26989127 DOI: 10.1093/neuonc/nov267  1
2015 Armstrong TS, Grant R, Gilbert MR, Lee JW, Norden AD. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro-Oncology. PMID 26527735 DOI: 10.1093/neuonc/nov269  1
2015 Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. Journal of Neuro-Oncology. PMID 26354773 DOI: 10.1007/s11060-015-1930-y  1
2015 Ladha H, Pawar T, Gilbert MR, Mandel J, O-Brien B, Conrad C, Fields M, Hanna T, Loch C, Armstrong TS. Wound healing complications in brain tumor patients on Bevacizumab. Journal of Neuro-Oncology. PMID 26298437 DOI: 10.1007/s11060-015-1868-0  1
2015 Armstrong TS, Vera-Bolanos E, Acquaye AA, Gilbert MR, Ladha H, Mendoza T. The symptom burden of primary brain tumors: evidence for a core set of tumor and treatment-related symptoms. Neuro-Oncology. PMID 26289592 DOI: 10.1093/neuonc/nov166  1
2015 Acquaye AA, Lin L, Vera-Bolanos E, Gilbert MR, Armstrong TS. Hope and mood changes throughout the primary brain tumor illness trajectory. Neuro-Oncology. PMID 26109686 DOI: 10.1093/neuonc/nov101  1
2015 Yust-Katz S, Mandel JJ, Wu J, Yuan Y, Webre C, Pawar TA, Lhadha HS, Gilbert MR, Armstrong TS. Venous thromboembolism (VTE) and glioblastoma. Journal of Neuro-Oncology. 124: 87-94. PMID 25985958 DOI: 10.1007/s11060-015-1805-2  1
2015 Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, ... ... Armstrong TS, et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell. 27: 728-43. PMID 25965575 DOI: 10.1016/j.ccell.2015.04.002  1
2015 Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel JS. Genetic Modulation of Neurocognitive Function in Glioma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3340-6. PMID 25904748 DOI: 10.1158/1078-0432.CCR-15-0168  1
2015 Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert MR, Brown PD, Vardy J, Chung C. The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic. Neuro-Oncology. 17: 1114-20. PMID 25862766 DOI: 10.1093/neuonc/nov054  1
2015 Lin L, Chien LC, Acquaye AA, Vera-Bolanos E, Gilbert MR, Armstrong TS. Significant predictors of patients' uncertainty in primary brain tumors. Journal of Neuro-Oncology. 122: 507-15. PMID 25805495 DOI: 10.1007/s11060-015-1756-7  1
2015 Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathologica. 129: 585-96. PMID 25701198 DOI: 10.1007/s00401-015-1398-z  1
2015 Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathology. 32: 105-11. PMID 25388523 DOI: 10.1007/s10014-014-0205-1  1
2015 Walbert T, Mendoza TR, Vera-Bolaños E, Acquaye A, Gilbert MR, Armstrong TS. Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2. Journal of Neuro-Oncology. 121: 341-8. PMID 25359395 DOI: 10.1007/s11060-014-1638-4  0.6
2015 Brassil KJ, Engebretson JC, Armstrong TS, Segovia JH, Worth LL, Summers BL. Exploring the Cancer Experiences of Young Adults in the Context of Stem Cell Transplantation. Cancer Nursing. 38: 260-9. PMID 25232959 DOI: 10.1097/NCC.0000000000000200  1
2015 Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, Colman H, Dhall G, Lieberman FS, Metellus P, Mikkelsen T, Omuro A, Partap S, Prados M, Robins HI, ... ... Armstrong TS, et al. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neuro-Oncology. 17: 440-7. PMID 25121770 DOI: 10.1093/neuonc/nou162  1
2014 Kamiya-Matsuoka C, Cachia D, Olar A, Armstrong TS, Gilbert MR. Primary brain tumors and posterior reversible encephalopathy syndrome. Neuro-Oncology Practice. 1: 184-190. PMID 26034631 DOI: 10.1093/nop/npu024  1
2014 Cahill JE, Lin L, LoBiondo-Wood G, Armstrong TS, Acquaye AA, Vera-Bolanos E, Gilbert MR, Padhye NS. Personal health records, symptoms, uncertainty, and mood in brain tumor patients. Neuro-Oncology Practice. 1: 64-70. PMID 26034618 DOI: 10.1093/nop/npu005  1
2014 Armstrong TS, Vera-Bolanos E, Acquaye A, Gilbert MR, Mendoza TR. Impact of recall period on primary brain tumor patient's self-report of symptoms. Neuro-Oncology Practice. 1: 55-63. PMID 26034617 DOI: 10.1093/nop/npu006  1
2014 Gilbert MR, Armstrong TS, Pope WB, van den Bent MJ, Wen PY. Facing the future of brain tumor clinical research. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5591-600. PMID 25398842 DOI: 10.1158/1078-0432.CCR-14-0835  1
2014 Brady VJ, Grimes D, Armstrong T, LoBiondo-Wood G. Management of steroid-induced hyperglycemia in hospitalized patients with cancer: a review. Oncology Nursing Forum. 41: E355-65. PMID 25355031 DOI: 10.1188/14.ONF.E355-E365  1
2014 Armstrong TS, Mendoza TR. Response to Lai et al., "development of a symptom index for patients with primary brain tumors". Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 752-3. PMID 25237001 DOI: 10.1016/j.jval.2014.06.004  0.8
2014 Armstrong TS, Gilbert MR. Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients. Current Treatment Options in Oncology. 15: 519-28. PMID 25173554 DOI: 10.1007/s11864-014-0302-8  1
2014 Corwin EJ, Berg JA, Armstrong TS, DeVito Dabbs A, Lee KA, Meek P, Redeker N. Envisioning the future in symptom science. Nursing Outlook. 62: 346-51. PMID 25085330 DOI: 10.1016/j.outlook.2014.06.006  1
2014 Armstrong TS. 2013 Special Topics Conference: Peaks and pitfalls in longitudinal studies of symptom outcome data. Nursing Outlook. 62: 305-12. PMID 25015407 DOI: 10.1016/j.outlook.2014.05.005  1
2014 Tsai CJ, Wang Y, Allen PK, Mahajan A, McCutcheon IE, Rao G, Rhines LD, Tatsui CE, Armstrong TS, Maor MH, Chang EL, Brown PD, Li J. Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience. Neurosurgery. 75: 205-14; discussion 2. PMID 24818785 DOI: 10.1227/NEU.0000000000000408  1
2014 Gilbert MR, Dignam J, Pugh S, Armstrong TS, Wefel JS, Aldape K, Stupp R, Hegi M, Won M, Curran WJ, Mehta MP. Reply to M.C. Chamberlain. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1634-5. PMID 24752060 DOI: 10.1200/JCO.2013.54.9717  1
2014 Yust-Katz S, de Groot JF, Liu D, Wu J, Yuan Y, Anderson MD, Conrad CA, Milbourne A, Gilbert MR, Armstrong TS. Pregnancy and glial brain tumors. Neuro-Oncology. 16: 1289-94. PMID 24615863 DOI: 10.1093/neuonc/nou019  1
2014 Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. The New England Journal of Medicine. 370: 699-708. PMID 24552317 DOI: 10.1056/NEJMoa1308573  1
2014 Cahill JE, Gilbert MR, Armstrong TS. Personal health records as portal to the electronic medical record. Journal of Neuro-Oncology. 117: 1-6. PMID 24477621 DOI: 10.1007/s11060-013-1333-x  1
2013 Dignam J, Won M, Blumenthal DT, Vogelbaum MA, Aldape KD, Colman H, Chakravarti A, Jeraj R, Armstrong TS, Wefel JS, Brown PD, Jaeckle KA, Schiff D, Atkins JN, Brachman D, et al. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1. PMID 28136057 DOI: 10.1200/jco.2013.31.18_suppl.1  0.68
2013 Armstrong TS, Wefel JS, Wang M, Gilbert MR, Won M, Bottomley A, Mendoza TR, Coens C, Werner-Wasik M, Brachman DG, Choucair AK, Mehta M. Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4076-84. PMID 24101048 DOI: 10.1200/JCO.2013.49.6067  1
2013 Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4085-91. PMID 24101040 DOI: 10.1200/JCO.2013.49.6968  1
2013 Ghia AJ, Mahajan A, Allen PK, Armstrong TS, Lang FF, Gilbert MR, Brown PD. Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis. Journal of Neuro-Oncology. 115: 513-20. PMID 24085643 DOI: 10.1007/s11060-013-1254-8  1
2013 Acquaye AA, Vera-Bolanos E, Armstrong TS, Gilbert MR, Lin L. Mood disturbance in glioma patients. Journal of Neuro-Oncology. 113: 505-12. PMID 23677748 DOI: 10.1007/s11060-013-1143-1  1
2013 Lin L, Chiang HH, Acquaye AA, Vera-Bolanos E, Gilbert MR, Armstrong TS. Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling. Cancer. 119: 2796-806. PMID 23661311 DOI: 10.1002/cncr.28121  1
2013 Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, et al. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathology (Zurich, Switzerland). 23: 584-94. PMID 23452038 DOI: 10.1111/bpa.12050  1
2013 Armstrong TS. Measuring clinical benefit: use of patient-reported outcomes (PRO) in primary brain tumor clinical trials. Current Oncology Reports. 15: 27-32. PMID 23054936 DOI: 10.1007/s11912-012-0276-2  1
2012 Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro-Oncology. 14: iv65-72. PMID 23095832 DOI: 10.1093/neuonc/nos210  1
2012 Lin L, Acquaye AA, Vera-Bolanos E, Cahill JE, Gilbert MR, Armstrong TS. Validation of the Mishel's uncertainty in illness scale-brain tumor form (MUIS-BT). Journal of Neuro-Oncology. 110: 293-300. PMID 22965831 DOI: 10.1007/s11060-012-0971-8  1
2012 Amirian ES, Armstrong TS, Aldape KD, Gilbert MR, Scheurer ME. Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007. Neuroepidemiology. 39: 116-24. PMID 22846789 DOI: 10.1159/000339320  1
2012 Cahill J, LoBiondo-Wood G, Bergstrom N, Armstrong T. Brain tumor symptoms as antecedents to uncertainty: an integrative review. Journal of Nursing Scholarship : An Official Publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau. 44: 145-55. PMID 22564342 DOI: 10.1111/j.1547-5069.2012.01445.x  1
2012 Galanis E, Wu W, Cloughesy T, Lamborn K, Mann B, Wen PY, Reardon DA, Wick W, Macdonald D, Armstrong TS, Weller M, Vogelbaum M, Colman H, Sargent DJ, van den Bent MJ, et al. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. The Lancet. Oncology. 13: e196-204. PMID 22554547 DOI: 10.1016/S1470-2045(11)70406-5  1
2012 Armstrong TS, Wefel JS, Gning I, Acquaye A, Vera-Bolanos E, Gilbert MR, Cleeland CS, Mendoza T. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 118: 5026-37. PMID 22415423 DOI: 10.1002/cncr.27483  1
2012 Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R, Vaillant B, Goldman S, Packer RJ, Fouladi M, Pollack I, Mikkelsen T, Prados M, Omuro A, Soffietti R, et al. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathologica. 123: 727-38. PMID 22322993 DOI: 10.1007/s00401-012-0941-4  1
2012 Armstrong TS, Wen PY, Gilbert MR, Schiff D. Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors. Neuro-Oncology. 14: 1203-14. PMID 22307472 DOI: 10.1093/neuonc/nor223  1
2012 Penas-Prado M, Armstrong TS, Gilbert MR. Glioblastoma. Handbook of Clinical Neurology. 105: 485-506. PMID 22230514 DOI: 10.1016/B978-0-444-53502-3.00004-5  1
2012 Amirian ES, Armstrong TS, Gilbert MR, Scheurer ME. Predictors of survival among older adults with ependymoma. Journal of Neuro-Oncology. 107: 183-9. PMID 21952907 DOI: 10.1007/s11060-011-0730-2  1
2011 Shonka NA, Armstrong TS, Prabhu SS, Childress A, Choi S, Langford LA, Gilbert MR. Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review. Journal of Clinical Medicine Research. 3: 85-92. PMID 21811535 DOI: 10.4021/jocmr535w  1
2011 Armstrong TS, Vera-Bolanos E, Gilbert MR. Clinical course of adult patients with ependymoma: results of the Adult Ependymoma Outcomes Project. Cancer. 117: 5133-41. PMID 21538344 DOI: 10.1002/cncr.26181  1
2011 Cahill JE, Armstrong TS. Caring for an adult with a malignant primary brain tumor. Nursing. 41: 28-33; quiz 33-4. PMID 21537213 DOI: 10.1097/01.NURSE.0000397930.50420.c6  1
2011 van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. The Lancet. Oncology. 12: 583-93. PMID 21474379 DOI: 10.1016/S1470-2045(11)70057-2  1
2011 Armstrong TS, Vera-Bolanos E, Gning I, Acquaye A, Gilbert MR, Cleeland C, Mendoza T. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 117: 3222-8. PMID 21264841 DOI: 10.1002/cncr.25892  1
2011 Armstrong TS, Gilbert MR. Patient profiling for treatment toxicity: potential use of clinical and genomic factors. Current Oncology Reports. 13: 37-41. PMID 21080116 DOI: 10.1007/s11912-010-0141-0  1
2011 Armstrong TS, Prabhu S, Aldape K, Hossan B, Kang S, Childress A, Tolentino L, Gilbert MR. A case of soft tissue metastasis from glioblastoma and review of the literature. Journal of Neuro-Oncology. 103: 167-72. PMID 20809248 DOI: 10.1007/s11060-010-0370-y  1
2010 Armstrong TS, Vera-Bolanos E, Bekele BN, Aldape K, Gilbert MR. Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience. Neuro-Oncology. 12: 862-70. PMID 20511182 DOI: 10.1093/neuonc/noq009  1
2010 Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, Tsavachidis S, Liang FW, Gilbert M, Aldape K, Armstrong T, Houlston R, Hosking F, Robertson L, Xiao Y, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2467-74. PMID 20368557 DOI: 10.1200/JCO.2009.26.6213  1
2010 Armstrong TS, Gning I, Mendoza TR, Vera-Bolanos E, Gilbert MR, Rhines LD, Weinberg JS, Sanchez-Williams G, Levin V, Burton AW, Cleeland C. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. Journal of Neurosurgery. Spine. 12: 421-30. PMID 20367379 DOI: 10.3171/2009.10.SPINE0943  1
2010 Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 116: 2707-15. PMID 20235192 DOI: 10.1002/cncr.25018  1
2010 Armstrong TS, Choi S, Walker J, Gilbert MR. Seizure risk in brain tumor patients with conversion to generic levetiracetam. Journal of Neuro-Oncology. 98: 137-41. PMID 19936624 DOI: 10.1007/s11060-009-0066-3  1
2009 Armstrong TS. Head's up on the treatment of malignant glioma patients. Oncology Nursing Forum. 36: E232-40. PMID 19726382 DOI: 10.1188/09.ONF.E232-E240  1
2009 Lambert LA, Armstrong TS, Lee JJ, Liu S, Katz MH, Eng C, Wolff RA, Tortorice ML, Tansey P, Gonzalez-Moreno S, Lambert DH, Mansfield PF. Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. Annals of Surgical Oncology. 16: 2181-7. PMID 19475451 DOI: 10.1245/s10434-009-0523-4  1
2009 Armstrong TS, Cao Y, Scheurer ME, Vera-Bolaños E, Manning R, Okcu MF, Bondy M, Zhou R, Gilbert MR. Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro-Oncology. 11: 825-32. PMID 19179423 DOI: 10.1215/15228517-2008-120  1
2009 Armstrong TS, Gning I, Mendoza TR, Weinberg JS, Gilbert MR, Tortorice ML, Cleeland CS. Clinical utility of the MDASI-BT in patients with brain metastases. Journal of Pain and Symptom Management. 37: 331-40. PMID 18676120 DOI: 10.1016/j.jpainsymman.2008.02.011  1
2008 Armstrong TS, Gilbert MR. Use of complementary and alternative medical therapy by patients with primary brain tumors. Current Neurology and Neuroscience Reports. 8: 264-8. PMID 18541122 DOI: 10.1007/s11910-008-0040-z  1
2008 Lee EL, Armstrong TS. Increased intracranial pressure. Clinical Journal of Oncology Nursing. 12: 37-41. PMID 18258573 DOI: 10.1188/08.CJON.37-41  1
2008 Tremont-Lukats I, Ratilal BO, Armstrong T, Gilbert MR. Antiepileptic drugs for preventing seizures in people with brain tumors Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD004424.pub2  1
2007 Gilbert MR, Armstrong TS. Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide. Therapeutics and Clinical Risk Management. 3: 1027-33. PMID 18516257  1
2007 Westcarth L, Armstrong T. Seizures in people with cancer Clinical Journal of Oncology Nursing. 11: 33-37. PMID 17441395  1
2007 Armstrong TS, Gilbert MR. Net clinical benefit: functional endpoints in brain tumor clinical trials. Current Oncology Reports. 9: 60-5. PMID 17164049 DOI: 10.1007/BF02951427  1
2006 Armstrong T, Cohen MZ, Hess KR, Manning R, Lee EL, Tamayo G, Baumgartner K, Min SJ, Yung A, Gilbert M. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. Journal of Pain and Symptom Management. 32: 148-54. PMID 16877182 DOI: 10.1016/j.jpainsymman.2006.02.015  1
2006 Armstrong TS, Mendoza T, Gning I, Gring I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). Journal of Neuro-Oncology. 80: 27-35. PMID 16598415 DOI: 10.1007/s11060-006-9135-z  1
2005 Armstrong TS, Cohen MZ, Eriksen L, Cleeland C. Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory. Oncology Nursing Forum. 32: 669-76. PMID 15897941 DOI: 10.1188/05.ONF.669-676  1
2005 Armstrong T, Almadrones L, Gilbert MR. Chemotherapy-induced peripheral neuropathy Oncology Nursing Forum. 32: 305-311. PMID 15759068 DOI: 10.1188/05.ONF.305-311  1
2004 Armstrong TS, Cohen MZ, Weinberg J, Gilbert MR. Imaging techniques in neuro-oncology. Seminars in Oncology Nursing. 20: 231-9. PMID 15612599 DOI: 10.1016/j.soncn.2004.07.003  1
2004 Armstrong TS. Intracranial tumors. Seminars in Oncology Nursing. 20: 221-3. PMID 15612597 DOI: 10.1016/j.soncn.2004.07.001  1
2004 Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. Journal of Nursing Scholarship : An Official Publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau. 36: 197-206. PMID 15495487 DOI: 10.1111/j.1547-5069.2004.04038.x  1
2004 Armstrong TS, Gilbert MR. The treatment of neoplastic meningitis. Expert Opinion On Pharmacotherapy. 5: 1929-35. PMID 15330730 DOI: 10.1517/14656566.5.9.1929  1
2004 Armstrong T, Gilbert MR. Central nervous system toxicity from cancer treatment Current Oncology Reports. 6: 11-19. PMID 14664755  1
2003 Armstrong TS. Symptoms experience: a concept analysis. Oncology Nursing Forum. 30: 601-6. PMID 12861321 DOI: 10.1188/03.ONF.601-606  1
2003 Armstrong TS, Kanusky JT, Gilbert MR. Seize the moment to learn about epilepsy in people with cancer. Clinical Journal of Oncology Nursing. 7: 163-9. PMID 12696212 DOI: 10.1188/03.CJON.163-169  1
2002 Armstrong TS, Gilbert MR. Glial tumors--new approaches in chemotherapy. The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses. 34: 326-30. PMID 12506816  1
2000 Armstrong T, Hancock C. Temodar offers promise for treating astrocytomas Clinical Journal of Oncology Nursing. 4: 159-160. PMID 2001136677  1
2000 Armstrong TS, Gilbert MR. Metastatic brain tumors: diagnosis, treatment, and nursing interventions. Clinical Journal of Oncology Nursing. 4: 217-25. PMID 11111453  1
2000 Gilbert M, Armstrong T, Meyers C. Issues in assessing and interpreting quality of life in patients with malignant glioma Seminars in Oncology. 27: 20-26. PMID 10866346  1
2000 Armstrong T, Hancock C, Gilbert M. Symptom management of the patient with a brain tumor at the end of life Oncology Nursing Forum. 27: 616. PMID 10833685  1
2000 Armstrong T, Gilbert MR. Article on deep vein thrombosis should address primary brain tumors Oncology Nursing Forum. 27: 426-427. PMID 10785896  1
1999 Armstrong TS. Harvesting hope in the autumn of life. Clinical Journal of Oncology Nursing. 3: 23-8. PMID 10232169  1
1998 Armstrong TS, Gilbert MR. Chemotherapy of astrocytomas: an overview. Seminars in Oncology Nursing. 14: 18-25. PMID 9503511  1
1996 Armstrong TS, Gilbert MR. Glial neoplasms: classification, treatment, and pathways for the future. Oncology Nursing Forum. 23: 615-25; quiz 626-7. PMID 8735320  1
1995 Gilbert MR, Armstrong TS. Management of seizures in the adult patient with cancer. Cancer Practice. 3: 143-9. PMID 7599670  1
1994 Armstrong TS. Stomatitis in the bone marrow transplant patient. An overview and proposed oral care protocol. Cancer Nursing. 17: 403-10. PMID 7954388  1
Show low-probability matches.